'Targeting the Middle East Market' Lunit Supplies AI Diagnostic Solutions to Saudi Arabia's Largest Medical Institution

Breast Cancer Diagnosis AI Solution 'Lunit Insight MMG'
"Accelerating Middle East Market Expansion"

Medical AI company Lunit announced on the 26th that it has signed a contract to supply breast cancer diagnosis AI solutions to all hospitals under Dr. Sulaiman Al-Habib Medical Group (HMG), the largest private healthcare institution in Saudi Arabia and the Middle East.

Jae-Min Oh (center), VP of Business Development at Lunit, recently signed a contract for the supply of artificial intelligence (AI) solutions in Saudi Arabia, along with Abdulelah Al Mayman (right), Cloud Solutions representative of Sulayman Al-Habib Medical Group (HMG), and other HMG officials.
[Photo by Lunit]

HMG is the largest private healthcare institution in the Middle East headquartered in Saudi Arabia, operating more than 20 hospitals across the Middle East, including Saudi Arabia, the United Arab Emirates (UAE), and Bahrain.

Over the next three years, Lunit will provide HMG with its AI-based breast cancer diagnosis solution, 'Lunit Insight MMG,' which HMG plans to use for the national breast cancer screening program in Saudi Arabia. In particular, Lunit intends to actively pursue technical collaboration to advance the AI technology of its products through HMG’s cloud AI platform.

Additionally, Lunit plans to supply its chest X-ray image analysis solution 'Lunit Insight CXR' and digital breast tomosynthesis image analysis solution 'Lunit Insight DBT' to HMG within this year. Lunit explained that Lunit Insight DBT analyzes three-dimensional (3D) breast tomosynthesis images quickly and accurately, enabling more precise examinations compared to existing 2D products.

Earlier this month, Lunit announced its participation in the 'SEHA Virtual Hospital' project, a public healthcare initiative under Saudi Arabia’s national 'Vision 2030' led by Crown Prince Mohammed bin Salman. With this supply contract with HMG, Lunit has achieved its first collaboration in the Saudi private healthcare sector.

Seobum Seok, CEO of Lunit, stated, "Since recently participating in Saudi Arabia’s public healthcare national strategic projects, Lunit is expanding into the private sector and accelerating its penetration into the Middle Eastern market. Especially, following expansions into Australia at the end of last year and Sweden last month, we are continuously expanding our national-level cancer screening business (B2G) up to Saudi Arabia."

According to global market research firm Data Bridge, the medical imaging market in the Middle East was valued at $2.01 billion (approximately 2.5 trillion KRW) in 2021. It is expected to grow to $3.085 billion (approximately 3.8 trillion KRW) by 2029, with a compound annual growth rate (CAGR) of 5.5% during this period.

This content was produced with the assistance of AI translation services.